Sumitomo Mitsui Trust Group, Inc.
Position in CAI — Caris Life Sciences, Inc.
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in CAI
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$978,139
-$36,443 QoQ
Shares Held
54,890
-3.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 246 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sumitomo Mitsui Trust Group, Inc. holds $1,307,870,799 across 36 Biotechnology names. CAI ranks #26 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
611,907 | $303,952,564 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
282,199 | $175,962,364 | |
| 3 | TECH |
BIO-TECHNE Corp
|
2,067,324 | $146,056,440 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
3,455,043 | $118,577,075 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
325,379 | $97,948,840 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
1,720,734 | $93,848,832 | |
| 7 | RPRX |
Royalty Pharma plc
|
1,187,943 | $66,607,964 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
306,300 | $57,363,864 |
All Filings in CAI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $978,139 | 54,890 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $1,014,582 | 56,744 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $2,032,403 | 75,330 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $1,801,448 | 59,552 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $325,476 | 12,181 | Shares | Defined | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||